Third Harmonic Bio, Inc. (THRD)
NASDAQ: THRD · Real-Time Price · USD
10.84
-0.04 (-0.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
Third Harmonic Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 20.96 | 19.99 | 13.3 | 3.26 | 1.17 |
| Research & Development | 31.88 | 23.96 | 24.41 | 15.75 | 9.95 |
| Operating Expenses | 52.84 | 43.95 | 37.71 | 19 | 11.12 |
| Operating Income | -52.84 | -43.95 | -37.71 | -19 | -11.12 |
| Interest Expense | - | - | -0 | - | - |
| Interest & Investment Income | 13.67 | 13.13 | 2.56 | 0.01 | - |
| EBT Excluding Unusual Items | -39.2 | -30.82 | -35.16 | -19 | -11.12 |
| Other Unusual Items | - | - | - | -10.61 | -1.69 |
| Pretax Income | -39.2 | -30.82 | -35.16 | -29.61 | -12.81 |
| Net Income | -39.2 | -30.82 | -35.16 | -29.61 | -12.81 |
| Net Income to Common | -39.2 | -30.82 | -35.16 | -29.61 | -12.81 |
| Shares Outstanding (Basic) | 40 | 40 | 14 | 4 | 4 |
| Shares Outstanding (Diluted) | 40 | 40 | 14 | 4 | 4 |
| Shares Change (YoY) | 2.31% | 176.21% | 254.97% | 10.23% | - |
| EPS (Basic) | -0.97 | -0.78 | -2.45 | -7.32 | -3.49 |
| EPS (Diluted) | -0.97 | -0.78 | -2.45 | -7.32 | -3.49 |
| Free Cash Flow | -28.88 | -20.59 | -34.95 | -15.75 | -9.19 |
| Free Cash Flow Per Share | -0.71 | -0.52 | -2.44 | -3.89 | -2.50 |
| EBITDA | -52.79 | -43.92 | -37.71 | - | - |
| D&A For EBITDA | 0.05 | 0.04 | 0 | - | - |
| EBIT | -52.84 | -43.95 | -37.71 | -19 | -11.12 |
Source: S&P Capital IQ. Standard template.
Financial Sources.